What Happened?
San Francisco, -based Jaguar-Health Promoted Jonathan Wolin as Chief of Staff, Chief Compliance Officer and General Counsel
About the Company
Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Our wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Our Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
About the Person
Jonathan Wolin is Chief of Staff, Chief Compliance Officer and General Counsel at Jaguar Health. Previously, Jonathan held various senior legal leadership roles in the industry.
Info Source
News
Short Profile